| |
|
|
|
Agile Therapeutics Inc.  
|
|
1.18 -0.01 (-0.01%) |
10-18 16:00 |
|
Open: |
1.19 |
Pre close: |
1.19 |
Target:
|
1.51 
|
|
High: |
1.22 |
Low: |
1.17 |
Resistance:
|
1.30
1.46
|
|
Volume: |
594,071 |
Market Cap: |
70M |
Support:
|
1.04
0.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.20
 |
MACD |
MACD(12,26):
|
-0.00 |
|
MA(20): |
1.14 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
1.24 |
Stochastic Oscillator |
%K(14,3):
|
61.98 |
|
MA(250): |
1.14 |
%D(3): |
69.22 |
|
Average Volume(K) |
3-Month: |
86098
|
52-Week |
High:
|
1.70 |
|
10-Days: |
109633 |
Low: |
0.53 |
|
RSI |
RSI(14):
|
49.96 |
Change(%): |
23.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.420 |
Return on Equity (ttm) |
-63.9 |
Shares Out. (M) |
59.30 |
|
EPS Est. Current Year |
-1.020 |
Return on Assets (ttm) |
-30.5 |
Shares Float (M) |
30.97 |
|
EPS Est. Next Year |
-0.980 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.27 |
|
EPS Est. Next Quarter |
-0.260 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
54.21 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
362 |
|
Book Value (p.s.) |
0.520 |
EBITDA (p.s.) |
-0.251 |
P/E |
-2.81 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.27 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.33 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-8.26 |
P/CF |
-4.88 |
|
|
|
|
|
|
